20141015 Banner -- HINJ 184 2014_Reimbursement_228x180 - Copy

 

 

 HINJ 2013 Economic Impact Report

Download ‘HINJ’s 2013
Economic Impact Report’

 

HINJ and New Jersey's Life Sciences Community Brochure

Download HINJ and New
Jersey’s Life Sciences Community

 

Building-Bridges 

Download the Report

 

 

at life sciences celebration 2014, hinj honors rep. holt, dr. joachim kohn, students 2 science and leukemia & lymphoma society

On October 8, 2014, HINJ honored two New Jersey leaders and two organizations for their contributions in public service, life sciences research, STEM education and patient advocacy. 

HINJ’s 2014 honorees were:

  • The Honorable Bob Franks Public Service Award: The Honorable Rush Holt, United States Representative, New Jersey (CD 12)
  • Research: Joachim Kohn, Ph.D., FBSE, Director, New Jersey Center for Biomaterials, Board of Governors Professor of Chemistry, Rutgers, The State University of New Jersey
  • STEM Education: Students 2 Science, Inc.
  • Patient Advocacy: Leukemia & Lymphoma Society’s New Jersey Chapter

HINJ’s guest speaker was Ethan Zohn, CBS “Survivor” winner, cancer crusher and co-founder of Grassroot Soccer.

For the complete story, click here.

 ROGER CROP R94A2923 10_08_14

Front (l. to r.): Gina Murdoch, LLS-NJ; HINJ’s Dean Paranicas; Gina Londino, LLS-NJ.  Back (l. to r.): HINJ Chair Craig Bleifer, Daiichi Sankyo, Inc.; Larry Fox, Dr. Paul Winslow, Don Truss, Students 2 Science; U.S. Rep. Rush Holt; Dr. Joachim Kohn, NJ Center for Biomaterials; “Survivor” Ethan Zohn; Mike Shevlin, Chair, LLS-NJ.

 

 

HINJ RESPONDS TO NPR REPORT ON NEW JERSEY’S BIOPHARMA SECTOR

HINJ has responded as follows to a National Public Radio (NPR) report regarding New Jersey’s biopharmaceutical sector.  HINJ said:

“Dan Tucker’s story opens by stating that New Jersey “used to be known as ‘the nation’s medicine chest.’”  While [HINJ] acknowledges that there are a number of vacant pharmaceutical facilities in the state, the status of industry real estate alone is not a true barometer of the industry’s strength in New Jersey.

“HINJ contends that — with 13 of the world’s top 20 biopharmaceutical companies and 12 of the world’s top 20 medical technology companies maintaining a significant presence in New Jersey, with the state being one of the largest life sciences clusters in the U.S., and with recent expansion and relocation activity in the state — the Garden State remains the “medicine chest of the world.”

“In contrast, this story leads the audience to infer a rather bleak picture and outlook for New Jersey’s life sciences community.

“In fact, there are a number of signs that point to an energized life sciences community in New Jersey that were not reflected in this story.”

For HINJ’s complete response to the NPR story, click here.

 

 

HINJ’S PARANICAS APPEARS ON ‘NJ CAPITOL REPORT’ TO DISCUSS STATE’S LIFE SCIENCES SECTOR

(l. to r.) Steve Adubato, Dean Paranicas and Rafael Pi Roman.

HINJ President and Chief Executive Officer Dean J. Paranicas appears  with Emmy Award-winning anchors Steve Adubato and Rafael Pi Roman on “New Jersey Capitol Report” to discuss New Jersey’s life sciences sector.

To view the half-hour episode — Paranicas begins at the 17:45-minute mark — click here.

For the complete story, click here.

 

 

HINJ  ANNOUNCES NEW BOARD, STEERING COMMITTEE LEADERSHIP; DAIICHI SANKYO EXECUTIVE CRAIG BLEIFER NAMED BOARD CHAIR

HINJ has announced new officers of its Board of Trustees as well as the leadership of its Steering Committee.

Craig B. Bleifer (photo), Vice President, General Counsel and Secretary, Daiichi Sankyo, Inc., has been named Chair of the HINJ Board of Trustees.

Mr. Bleifer succeeds Kevin T. Rigby, U.S. Country Head Public Affairs, Vice President Public Affairs, Novartis Pharmaceuticals Corporation. 

HINJ’s two new Board Vice Chairs are:

  • Yin C. Becker, Vice President, Communications, Public Affairs and Strategic Marketing, Stryker.
  • Raymond Sacchetti, Senior Vice President, U.S. Access and Government Affairs, Bristol-Myers Squibb Company.

For the complete HINJ leadership story, click here.

 

 

HINJ HOSTS LT. GOVERNOR GUADAGNO, CABINET MEMBERS FOR ROUNDTABLE DISCUSSION

Photo (left to right): HINJ President and CEO Dean J. Paranicas, HINJ Vice Chair Craig Bleifer (Daiichi Sankyo, Inc.), Lt. Governor Kim Guadagno and HINJ Chair Kevin Rigby (Novartis Pharmaceuticals Corporation).

On June 13, the HealthCare Institute of New Jersey (HINJ) hosted a roundtable discussion featuring New Jersey Lt. Governor Kim Guadagno on the state of the life sciences and prospects for industry growth in the Garden State as part of the HINJ Board of Trustees meeting.

Joining Lt. Governor Guadagno were State Treasurer Andrew P. Sidamon-Eristoff, Labor Commissioner Hal Wirths, New Jersey Economic Development Authority Chief Executive Officer Michele Brown and representatives from the Business Action Center and Choose New Jersey.

For additional information, click here.

 

 

HINJ RELEASES 2013 ECONOMIC IMPACT REPORT AND ‘HINJ AND NJ’S LIFE SCIENCES COMMUNITY’ BROCHURE

HINJ has released two new publications:  the 2013 Economic Impact Report and a new external (leave-behind) brochure entitled HINJ and New Jersey’s Life Sciences Community.

Printed copies of each publication are being mailed to HINJ member companies and to our many stakeholders, including members of New Jersey’s Congressional Delegation, Governor Christie and his administration and the State Legislature.

HINJ encourages members to employ these new publications, when appropriate, in their interactions with elected officials and other stakeholders.

For additional information, click here.

 

 

HINJ CEO INTERVIEW ON NJTV NEWS:  NJ WILL CONTINUE TO BE STRONG WITHIN MEDICAL INDUSTRY

New Jersey has traditionally served as headquarters for life sciences companies and been a major part of the medical industry.  In an interview broadcast on April 10 on “NJTV News with Mike Schneider,” HINJ President and Chief Executive Officer Dean Paranicas said he believes the state will continue to be strong even in the changing health care climate. 

 

While some limitations exist, and changes have occurred within the industry, Paranicas said that he is optimistic that New Jersey has outstanding assets that work in the state’s favor.

 

“I think we continue to be very important,” Paranicas said.  “We are very proud of the fact that we are known globally as the medicine chest of the world, and we certainly intend to keep it that way.”

 

For the complete story, click here.

 

 

HINJ AND WWFH-NJ TO HOST FREE ‘NAVIGATING THE POLICYMAKING PROCESS’ WORKSHOP ON MAY 1

Please join HINJ and We Work for Health New Jersey (WWFH-NJ) for “Navigating the Policymaking Process,” which will be held on Thursday, May 1 at Forsgate Country Club in Monroe Township.

 

The purpose of the May 1 panel discussion is to provide Rx4NJ partners and others in New Jersey’s patient advocacy community useful information on how to effectively navigate the policymaking process on behalf of their patient constituencies.

Speakers and panelists include Assemblyman Troy Singleton (D-7) and Amanda Woloshen, District Director, Office of Congressman Leonard Lance (R-NJ-7).

For additional information, click here.

 

 

HINJ PLEASED AGAIN TO COSPONSOR PHARMFEST; PHRMA CEO JOHN CASTELLANI KEYNOTED

HINJ was pleased to partner, once again, with Montclair State University to sponsor PharmFest, a premier forum that explores emerging issues and trends in the biopharmaceutical and medical technology industry. 

“PharmFest 2014: The Decade Ahead” was held on April 3 in the Conference Center on the campus of Montclair State University.

Keynote addresses were presented by John J. Castellani, President and Chief Executive Officer of the Pharmaceutical and Research Manufacturers of America (PhRMA) and Dr. Richard Evans, Founding Partner and Research Analyst at Sector & Sovereign Research, LLC and author of Health and Capital. 

For additional information, click here.

 

 

HINJ AND NEHI HOST ‘INNOVATION IN AN ERA OF PAYMENT REFORM’ FORUM

HINJ and NEHI (The Network for Excellence in Health Innovation) hosted a forum on “Innovation in an Era of Payment Reform: How Will New Jersey’s Life Sciences Companies Respond?” on April 1 at the Crowne Plaza in Monroe Township, NJ.

Health care payment reform is already transforming the way health care providers deliver care throughout the United States.  Payment reform will not only influence the quality and cost of health care, it will also impact innovation in New Jersey’s historically dynamic life sciences sector. 

HINJ and NEHI’s roundtable brought stakeholders and policymakers together from all New Jersey health care sectors to explore the opportunities for medical innovation in this new environment, the direction innovation could take, the potential challenges that will be involved, and how innovation can be a solution to lowering the cost of health care in this new payment model.

For additional information, click here.

 

 

‘NJTV NEWS’ REPORTS ON NJ LIFE SCIENCES, HINJ’S 2012 ECONOMIC IMPACT SURVEY

It has been called the crown jewel of the New Jersey economy.  Citing HINJ’s latest economic impact survey, Lauren Wanko reported on “NJTV News with Mike Schneider” that the biopharmaceutical and medical technology industries generated over $26 billion in economic impact for the Garden State in 2012. 

“We call this the ‘Medicine Chest of the World,’” said HINJ President and Chief Executive Officer Dean Paranicas.  “This is New Jersey’s premier industry.  In fact, we have the largest concentration of companies of its type in the world.” 

The HINJ economic impact study indicates a nearly 10 percent increase in economic activity from 2010. 

To view the NJTV News segment, click here.

 

 

HINJ MEMBER COMPANIES’ ECONOMIC IMPACT EXCEEDS $26 BILLION IN 2012, FINDS NEW STUDY CONDUCTED IN ASSOCIATION WITH DELOITTE

Key findings from the HINJ 2012 economic impact survey indicate that the life sciences continues to play a leading role in driving New Jersey’s economy and reinforces the state’s reputation as the “Medicine Chest of the World.”

According to the study, which was conducted by Deloitte for the ninth consecutive year, participating HINJ member companies had a total impact on New Jersey’s economy of $26.6* billion in calendar year 2012, a healthy increase of 9.9 percent from 2010.

“HINJ member companies continue to be a major force in New Jersey’s economy in their pursuit of advancing global health,” said Dean J. Paranicas, President and Chief Executive Officer of HINJ.  “Our enduring goal is for patients everywhere to have access to the medicines, therapies and medical technologies they critically need.”

The 2012 survey also measured participating HINJ member companies’ activities in research and development (R&D), vendor spending, capital spending, philanthropy, employment and compensation.

To read the complete news story, click here.

 

HINJ Honors Six at Inaugural Life Sciences Celebration

The HealthCare Institute of New Jersey (HINJ) honored five New Jersey leaders and a nationally recognized high school on September 25, 2013, for their contributions in human health, public service, patient advocacy, life sciences, and science, technology, engineering and mathematics (STEM) education. 

The awards were presented at HINJ’s inaugural Life Sciences Celebration, which was held at the Renaissance Woodbridge Hotel in Iselin, NJ.

Those recognized included former Governor Thomas H. Kean, the late United States Senator Frank R. Lautenberg, Dr. Christopher J. Molloy, Dr. Joseph R. Bertino, Dr. Debra L. Wentz, and Biotechnology High School.

HINJ was pleased to host three former New Jersey Governors.  In addition to Governor Kean, Governor Brendan Byrne and Governor James Florio attended the event.

To read the news story, click here.

 

WELCOME TO NEW HINJ.ORG

Thank you for visiting HealthCare Institute of New Jersey (HINJ) online — and welcome to our new website!

Since our founding in 1997, HINJ has served as the voice of New Jersey’s life sciences industry, which is comprised of biopharmaceutical and medical technology companies. 

Engaged in a broad range of activities throughout New Jersey, in Washington, DC and around the nation, HINJ’s work focuses on four key themes:

  • Promoting patient access to cutting-edge medicines, therapies and medical technologies
  • Bolstering an “Innovation Ecosystem” that develops advances in human health
  • Building awareness of the life sciences industry’s contributions to New Jersey’s economy
  • Helping advance corporate social responsibility, which is a hallmark of the life sciences companies

Our aim with this website is to provide information about these themes to the many who engage New Jersey’s life sciences community.

As we continue to expand our new website in the coming weeks, we hope you will find it to be a content-rich and easy-to-navigate resource.  We welcome your feedback as we move forward.

Sincerely,

Dean J. Paranicas
President and Chief Executive Officer

 

 

Password Reset

Please enter your e-mail address. You will receive a new password via e-mail.